
|Articles|November 1, 2004
Look to Cells, not Site, to Diagnose B-Cell Lymphoma
Because morphology, bcl-2 expression and multicentricity are the strongest predictive factors in multivariate analysis of PCDLBCL, Dr. Ellis proposes that primary subdivision of PCBCL according to anatomic location be abandoned in favor of classification by centroblast/immunoblast morphology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















